Memeti, Besard, et al. “Mottling As an Early Sign of Euglycemic Ketoacidosis Induced by SGLT-2 Inhibitors”. European Journal of Case Reports in Internal Medicine, vol. 12, no. 4, Mar. 2025, https://doi.org/10.12890/2025_005210.